| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vericel Corp | Director | Common Stock | 15.1K | $542K | $35.92 | Aug 6, 2025 | Direct |
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50K | May 20, 2025 | Direct | ||
| Vericel Corp | Director | Restricted Stock Unit | 3.2K | Apr 30, 2025 | Direct | ||
| ACCELERON PHARMA INC | SVP, CFO and Treasurer | Common Stock | 0 | $175.00 | Nov 19, 2021 | Direct | |
| ACCELERON PHARMA INC | SVP, CFO and Treasurer | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
| Decibel Therapeutics, Inc. | Director | Common Stock | 0 | $5.03 | Sep 25, 2023 | Direct | |
| Decibel Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 25, 2023 | Direct | ||
| Vericel Corp | Director | Stock Option (Right to Buy) | 0 | Aug 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VCEL | Vericel Corp | Aug 6, 2025 | 3 | -$232K | 4 | Aug 8, 2025 | Director |
| IVVD | Invivyd, Inc. | May 20, 2025 | 1 | $0 | 4 | May 22, 2025 | Director |
| VCEL | Vericel Corp | May 7, 2025 | 3 | -$261K | 4 | May 9, 2025 | Director |
| VCEL | Vericel Corp | Apr 30, 2025 | 4 | $0 | 4 | May 2, 2025 | Director |
| VCEL | Vericel Corp | Feb 12, 2025 | 6 | -$363K | 4 | Feb 14, 2025 | Director |
| VCEL | Vericel Corp | Nov 13, 2024 | 3 | -$363K | 4 | Nov 15, 2024 | Director |
| VCEL | Vericel Corp | Aug 7, 2024 | 6 | -$295K | 4 | Aug 9, 2024 | Director |
| IVVD | Invivyd, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| IVVD | Invivyd, Inc. | May 21, 2024 | 0 | $0 | 3 | May 23, 2024 | Director |
| VCEL | Vericel Corp | May 1, 2024 | 4 | $0 | 4 | May 3, 2024 | Director |
| DBTX | Decibel Therapeutics, Inc. | Sep 25, 2023 | 3 | $0 | 4 | Sep 25, 2023 | Director |
| DBTX | Decibel Therapeutics, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 14, 2023 | Director |
| VCEL | Vericel Corp | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
| VCEL | Vericel Corp | Apr 27, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
| DBTX | Decibel Therapeutics, Inc. | Oct 10, 2022 | 1 | $0 | 4 | Oct 12, 2022 | Director |
| DBTX | Decibel Therapeutics, Inc. | Oct 10, 2022 | 0 | $0 | 3 | Oct 12, 2022 | Director |
| VCEL | Vericel Corp | Apr 27, 2022 | 4 | $0 | 4 | Apr 29, 2022 | Director |
| XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 6 | $0 | 4 | Nov 22, 2021 | SVP, CFO and Treasurer |
| XLRN | ACCELERON PHARMA INC | Sep 23, 2021 | 13 | -$3.01M | 4 | Sep 24, 2021 | SVP, CFO and Treasurer |